These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 3274336)
1. In vivo potentiation of cyclosporine immunosuppression by calcium antagonists. Tesi RJ; Hong J; Butt KM; Jaffe BM; McMillen MA Transplant Proc; 1987 Feb; 19(1 Pt 2):1382-4. PubMed ID: 3274336 [TBL] [Abstract][Full Text] [Related]
2. Effects of a combined antigen-cyclosporine regimen in four transplantation models. Didlake R; Kakazaki K; Yoshimura N; Merrell R; Kahan BD Transplant Proc; 1987 Feb; 19(1 Pt 2):1281-3. PubMed ID: 3152626 [No Abstract] [Full Text] [Related]
3. Donor-specific transfusion and cyclosporine prolong allograft survival when given in the peroperative period. Cofer BR; Tchervenkov JI; Alexander JW; Barnwell SC Transplant Proc; 1991 Feb; 23(1 Pt 1):157-8. PubMed ID: 1990501 [No Abstract] [Full Text] [Related]
4. Total lymphoid irradiation and cyclosporine prolongs cardiac allograft survival in the sensitized rat model. Harland RC; Halperin EC; Yamaguchi Y; Ruiz P; Scroggs MW; Sanfilippo F; Bollinger RR Transplant Proc; 1989 Feb; 21(1 Pt 1):1118-9. PubMed ID: 2650071 [No Abstract] [Full Text] [Related]
5. Synergistic effect of UV-irradiated donor-specific transfusions with peritransplant cyclosporine on cardiac allograft survival in rats. Oluwole S; Lau H; Reemtsma K; Hardy MA Transplant Proc; 1987 Feb; 19(1 Pt 1):451-3. PubMed ID: 3274803 [No Abstract] [Full Text] [Related]
6. A new rat infection-heart transplant model: effect of infection on graft survival studies. Kobayashi J; Mavroudis C; Crawford SE; Zales VR; Backer CL J Heart Lung Transplant; 1993; 12(4):659-64. PubMed ID: 7690253 [TBL] [Abstract][Full Text] [Related]
7. Effect of combined administration of low dose cyclosporine A with a thromboxane synthetase inhibitor on acute cardiac allograft rejection. Sakurai Y; Kagawa K; Kato Y; Otani H; Nonoyama A Transplant Proc; 1990 Aug; 22(4):1686-8. PubMed ID: 2389433 [No Abstract] [Full Text] [Related]
8. Effect of FK 506 on heart allograft survival in highly sensitized recipient rats in comparison with cyclosporine. Jiang H; Takahara S; Takano Y; Li D; Kyo M; Valdivia LA; Kokado Y; Ishibashi M; Sonoda T Transplant Proc; 1991 Feb; 23(1 Pt 1):540-1. PubMed ID: 1703702 [No Abstract] [Full Text] [Related]
9. Comparison of the effect of a 5-mg/kg and 10-mg/kg cyclosporine loading dose with single and multiple donor-specific transfusions on rat cardiac allograft survival. Fisher RA; Cohen DS; Alexander JW; Davies CB; Schroeder TJ Transplant Proc; 1994 Oct; 26(5):3056-9. PubMed ID: 7940961 [No Abstract] [Full Text] [Related]
10. Effect of single-dose rapamycin-based immunosuppression on the development of cardiac allograft vasculopathy. Goggins WC; Fisher RA; Cohen DS; Tawes JW; Grimes MM J Heart Lung Transplant; 1996 Aug; 15(8):790-5. PubMed ID: 8878761 [TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive effects of leflunomide in a cardiac allograft model. Williams JW; Xiao F; Foster PF; Chong A; Sharma S; Bartlett R; Sankary HN Transplant Proc; 1993 Feb; 25(1 Pt 1):745-6. PubMed ID: 8438465 [No Abstract] [Full Text] [Related]
12. Survival of cardiac allograft in highly sensitized and nonsensitized rats treated with FK506. Takahara S; Jiang H; Ishibashi M; Okuyama A; Sonoda T J Clin Lab Immunol; 1991 Apr; 34(4):179-81. PubMed ID: 1726566 [TBL] [Abstract][Full Text] [Related]
13. Partial T-cell depletion with monoclonal antibody improves the enhancing effect of donor-specific transfusion plus cyclosporine. Brunson ME; Tchervenkov JI; Alexander JW; Cofer BR Transplant Proc; 1991 Feb; 23(1 Pt 1):307-8. PubMed ID: 1990538 [No Abstract] [Full Text] [Related]
14. Interaction between third-party blood transfusions and cyclosporine in rat heterotopic heart transplantation. McKenzie FN; Duplan J; Campbell C; Menkis A; Stiller C; Keown P; Kostuk W Transplant Proc; 1988 Dec; 20(6):1243-4. PubMed ID: 3059614 [No Abstract] [Full Text] [Related]
15. Effect of a new immunosuppressive agent, FK 506, on heterotopic cardiac allotransplantation in the rat. Ochiai T; Nakajima K; Nagata M; Suzuki T; Asano T; Uematsu T; Goto T; Hori S; Kenmochi T; Nakagoori T Transplant Proc; 1987 Feb; 19(1 Pt 2):1284-6. PubMed ID: 2484094 [No Abstract] [Full Text] [Related]
17. Correlation of the in vitro and in vivo immunosuppressive activity of brequinar sodium. Eiras-Hreha G; Cramer DV; Cajulis E; Cosenza C; Mills L; Hough K; Frankland M; Chapman F; Wang H; Zajac I Transplant Proc; 1993 Feb; 25(1 Pt 1):708-9. PubMed ID: 8438448 [No Abstract] [Full Text] [Related]
18. Interaction between rapamycin and pretransplant blood transfusions in rat heterotopic heart transplantation. Tucker MJ; Duplan J; Li X; Garcia B; Wijsman J; Stiller C; McKenzie FN Transplant Proc; 1993 Feb; 25(1 Pt 1):725-6. PubMed ID: 8438458 [No Abstract] [Full Text] [Related]
19. FTY720, a novel immunosuppressant possessing unique mechanisms. II. Long-term graft survival induction in rat heterotopic cardiac allografts and synergistic effect in combination with cyclosporine A. Hoshino Y; Suzuki C; Ohtsuki M; Masubuchi Y; Amano Y; Chiba K Transplant Proc; 1996 Apr; 28(2):1060-1. PubMed ID: 8623226 [No Abstract] [Full Text] [Related]
20. Prolongation of cardiac allograft survival by pretransplant administration of cyclosporine and donor-specific dendritic cells. Choti M; Lenrow D; Roza A; Markmann J; Naji A Transplant Proc; 1989 Feb; 21(1 Pt 1):478-9. PubMed ID: 2565055 [No Abstract] [Full Text] [Related] [Next] [New Search]